321 related articles for article (PubMed ID: 27782193)
1. Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.
Chiang KC; Yeh TS; Wu RC; Pang JS; Cheng CT; Wang SY; Juang HH; Yeh CN
Sci Rep; 2016 Oct; 6():36138. PubMed ID: 27782193
[TBL] [Abstract][Full Text] [Related]
2. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT.
Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X
Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
Xu Y; Wang Z; Jiang X; Cui Y
Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
[TBL] [Abstract][Full Text] [Related]
4. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W
Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506
[TBL] [Abstract][Full Text] [Related]
6. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.
Yang H; Lu X; Liu Z; Chen L; Xu Y; Wang Y; Wei G; Chen Y
Oncotarget; 2015 Mar; 6(8):6310-25. PubMed ID: 25749036
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.
Yang Y; Liu Y; He JC; Wang JM; Schemmer P; Ma CQ; Qian YW; Yao W; Zhang J; Qi WP; Fu Y; Feng W; Yang T
Oncotarget; 2016 Aug; 7(34):55191-55210. PubMed ID: 27409422
[TBL] [Abstract][Full Text] [Related]
10. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
11. GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma.
Deng X; Jiang P; Chen J; Li J; Li D; He Y; Jiang Y; Zhang Y; Xu S; Li X; Wang S; Tian F
Cell Death Dis; 2020 Oct; 11(10):860. PubMed ID: 33060563
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
13. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract][Full Text] [Related]
14. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
[TBL] [Abstract][Full Text] [Related]
15. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
[TBL] [Abstract][Full Text] [Related]
16. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma.
Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293
[TBL] [Abstract][Full Text] [Related]
17. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
18. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.
Boonjaraspinyo S; Boonmars T; Wu Z; Loilome W; Sithithaworn P; Nagano I; Pinlaor S; Yongvanit P; Nielsen PS; Pairojkul C; Khuntikeo N
Tumour Biol; 2012 Oct; 33(5):1785-802. PubMed ID: 22733151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]